|
|
||||||||
Eur J Cardiothorac Surg 1998;14:467-475
© 1998 Elsevier Science NL
Review article |
Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK
Received 25 May 1998; received in revised form 8 September 1998; accepted 8 September 1998.
Corresponding author. Tel.: +44 117 9283145; fax: +44 117 9299737.
Background: A major reduction in the energy demand of the myocardium results from the electromechanical arrest, and cooling contributes to a lesser degree to this reduction. It is from this assumption that strategies of myocardial protection, utilizing warm blood cardioplegic induction, followed by cold cardioplegia with terminal warm reperfusion before removal of the aortic cross clamp, became established as optimal myocardial protection. Continuous normothermic perfusion `closed the loop' by avoiding myocardial ischemia and linking warm induction and terminal reperfusion. A series of laboratory and clinical data confirmed the benefits of warm heart surgery on myocardial function and metabolism. The disadvantages of continuous warm blood cardioplegia including disturbance of the operative field, led surgeons to administer warm hyperkalaemic blood intermittently as a new cardioplegic strategy. Methods: This review examines the laboratory and clinical data with reference to the intermittent warm blood cardioplegia, to establish its experimental basis and place in clinical practice. Conclusions: Experimental observation and clinical application have established intermittent warm blood cardioplegia as a practical, effective and cheap myocardial protection technique, particulary with reference to coronary artery surgery.
Key Words: Myocardial protection Cold and warm blood cardioplegia
This article has been cited by other articles:
![]() |
M. Caputo, P. Modi, H. Imura, A. Pawade, A. J. Parry, M-S. Suleiman, and G. D. Angelini Cold blood versus cold crystalloid cardioplegia for repair of ventricular septal defects in pediatric heart surgery: a randomized controlled trial Ann. Thorac. Surg., August 1, 2002; 74(2): 530 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bessho and D. J. Chambers Myocardial protection: The efficacy of an ultra-short-acting {beta}-blocker, esmolol, as a cardioplegic agent J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 993 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Imura, M. Caputo, A. Parry, A. Pawade, G. D. Angelini, and M.-S. Suleiman Age-Dependent and Hypoxia-Related Differences in Myocardial Protection During Pediatric Open Heart Surgery Circulation, March 20, 2001; 103(11): 1551 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Abramov, M. G. Tamariz, S. E. Fremes, V. Guru, M. A. Borger, G. T. Christakis, G. Bhatnagar, J. Y. Sever, and B. S. Goldman Trends in coronary artery bypass surgery results: a recent, 9-year study Ann. Thorac. Surg., July 1, 2000; 70(1): 84 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. P. Elvenes, C. Korvald, L. M. Ytrebo, O. Irtun, T. Myrmel, T. S. Larsen, and D. Sorlie Myocardial metabolism and efficiency after warm continuous blood cardioplegia Ann. Thorac. Surg., June 1, 2000; 69(6): 1799 - 1805. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |